Delivery and vectors at Meeting on the Mesa 2026
64 organizations at Meeting on the Mesa 2026 present work in delivery: 33 suppliers and service providers and 31 therapy developers. Between them they bring 11 presentations to the program. Most represented: AviadoBio (1 on the program). 17 of them have their own page in this guide.
Format
Top represented
Showing 1–19 of 64 organizations
| Organization | Meeting on the Mesa 2026 Attendance |
|---|---|
Viralgen San Sebastian, Spain | ◆Platinum Sponsor |
Manufactures recombinant AAV vectors for gene therapy developers using a proprietary suspension platform and cGMP production facilities. | Spotlight Tue, Oct 6 2:15pm Innovation Spotlight company presentation |
GeneFab Alameda, CA | ◇Silver Sponsor |
Contract research and manufacturing organization providing development and cGMP production for cell, gene, vector, mRNA, LNP and plasmid therapies. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
Genezen Lexington, MA | ◆Diamond Sponsor |
Genezen provides viral vector development and cGMP manufacturing for AAV, lentiviral, and retroviral gene and cell therapy programs, from concept through commercial supply. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
◆Gold Sponsor | |
Makes equipment for formulating and manufacturing lipid nanoparticles and other nanocarriers, from screening through GMP production. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
MaxCyte Rockville, MD | ◇Silver Sponsor |
Provides electroporation systems and genotoxicity testing services for genetic engineering, cell therapy development, and GMP manufacturing. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
Oxford Biomedica Solutions Oxford, United Kingdom | ◇Silver Sponsor |
Develops and manufactures viral vectors, including lentivirus, AAV and adenovirus, for cell and gene therapy developers from early development through commercialization. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
◇Bronze Sponsor | |
Provides CRO/CDMO services for AAV, lentiviral vectors, plasmid DNA, mRNA and LNPs, including process development, analytics, cell banking and GMP manufacturing. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
Wacker Biotech Munich, Germany | ◆Platinum Sponsor |
Manufactures plasmid DNA, RNA and lipid nanoparticle formulations, providing development and GMP production for nucleic acid and gene therapy programs. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
AviadoBio London, United Kingdom | |
Develops targeted, one-time AAV gene therapies for frontotemporal dementia, retinitis pigmentosa and other neurodegenerative diseases. | Spotlight Mon, Oct 5 3:00pm Innovation Spotlight company presentation Panel Wed, Oct 7 4:00pm |
Avista Therapeutics Pittsburgh, PA | |
Develops AI-designed gene therapy vectors delivered by intravitreal injection to treat retinal diseases. | Spotlight Tue, Oct 6 4:30pm Innovation Spotlight company presentation |
Circio Oslo, Norway | |
Develops circVec, a circular RNA expression platform that improves gene therapy potency and durability through AAV and LNP delivery. | Spotlight Tue, Oct 6 9:15am Innovation Spotlight company presentation |
CPTx Munich, Germany | |
Develops non-viral, duration-tunable in vivo CAR-T therapies using immune-quiet DNA vectors and targeted lipid nanoparticles. | Spotlight Mon, Oct 5 3:15pm Innovation Spotlight company presentation |
CREATE Medicines Cambridge, MA | |
Develops in vivo mRNA-LNP therapies that program immune cells, including CAR therapies for autoimmune diseases and cancer. | Spotlight Tue, Oct 6 9:30am Innovation Spotlight company presentation |
Emmecell Menlo Park, CA | |
Develops magnetic cell-delivery technologies and regenerative cell therapies for corneal endothelial disease, geographic atrophy, and other eye conditions. | Spotlight Mon, Oct 5 9:45am Innovation Spotlight company presentation |
Latus Bio Philadelphia, PA | |
Develops targeted gene therapies for genetic diseases including CLN2 and Huntington’s disease. | Spotlight Mon, Oct 5 9:30am Innovation Spotlight company presentation |
Nionyx Bio New York City, NY | |
Develops human-selected AAV capsids and gene therapies for rare kidney diseases, targeting kidney cell types that are difficult to reach. | Spotlight Mon, Oct 5 2:45pm Innovation Spotlight company presentation Emerging Track |
Perpetuu Biosciences Rockville, MD | |
Develops single-administration AAV gene therapies for chronic hepatitis B, CMV prevention, and other serious viral diseases. | Spotlight Tue, Oct 6 2:00pm Innovation Spotlight company presentation Emerging Track |
Acuitas Therapeutics Vancouver, Canada | |
Develops lipid nanoparticle delivery systems that help drug developers deliver mRNA, siRNA and other nucleic acid medicines. | Attending On the meeting’s published attendee list |
Addition Therapeutics South San Francisco, CA | |
Develops all-RNA, lipid-nanoparticle genetic medicines designed as durable one-time treatments for rare and chronic diseases. | Attending On the meeting’s published attendee list |
Instantly find 20 buyers in delivery
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse Meeting on the Mesa 2026 by
Organization type
Focus area
Everyone
Not affiliated with or endorsed by the Alliance for Regenerative Medicine or the Cell & Gene Meeting on the Mesa. Submit a correction